APOE ε4, the door to insulin-resistant dyslipidemia and brain fog? A case study

For decades, scientists have known that carriers of the apolipoprotein E ε4 (APOE ε4) allele (homozygous/heterozygous) are at respectively higher risk for developing Alzheimer's disease (AD). Although previous research reveals that the APOE ε4 variant impacts the clearance capacity and degradat...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoykovich, Seth, Gibas, Kelly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423699/
https://www.ncbi.nlm.nih.gov/pubmed/30923733
http://dx.doi.org/10.1016/j.dadm.2019.01.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423699/
https://www.ncbi.nlm.nih.gov/pubmed/30923733
http://dx.doi.org/10.1016/j.dadm.2019.01.009

Ejemplares similares